a review of the literature investigating an alternative method of administering doxorubicin on a weekly basis demonstrates a lower incidence of doxorubicin-induced cardiomyopathy , as judged by endomyocardial biopsy techniques and by an apparent lower incidence of chf as compared to older reports in the literature utilizing conventional tri-weekly administration .
C0013089
doxorubicin
C0018802
chf